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This pilot double blind randomised controlled study aimed to investigate whether the midvastus (MV) approach without patellar
eversion in total knee arthroplasty (TKA) resulted in improved recovery of function compared to the medial parapatellar (MP)
approach. Patients were randomly allocated to either the MV approach or the MP approach. Achievements of inpatient mobility
milestones were recorded. Knee kinematics, muscle strength, Timed Up and Go, WOMAC, and daily step count were assessed
before and up to six months after surgery. Cohen’s effect size 𝑑 was calculated to inform the sample size in future trials. Twenty-
eight participants (16 males, 12 females) participated. Patient mobility milestones such as straight leg raise were achieved on average
1.3 days (95% CI −3.4 to 0.7, 𝑑 = 0.63) earlier in the MV group. Knee extensor strength at 6 weeks after surgery was higher (95% CI
−0.38 to 0.61, 𝑑 = 0.73) in the MV group. No trends for differences between the groups were observed in knee kinematics, TUG,
WOMAC, or step count. Our results suggest a short term advantage in the first 6 weeks after surgery of the MV approach over the
MP approach, but a larger study is required to confirm these findings. This trial is registered with NCT056445.
1. Introduction
Total knee replacement surgery for osteoarthritis has been
shown to be successful in relieving pain and improve
function and quality of life for the majority of patients.
However, continued efforts are directed to further optimise
the functional outcome of total knee surgery by attempting
to improve implant design [1, 2] and more recently the type
of surgical approach used. The term “minimally invasive
surgery” covers a variety of approaches including midvastus
and mini-parapatellar approaches with or without computer
navigation. Several authors have compared the effects on
outcome of the midvastus (MV) approach compared to the
more traditional medial parapatellar (MP) approach and
their results have been summarised by reviews [3–5] con-
cluding some early benefits onmobilitymilestone andmuscle
strength. However, only few studies [6–9] included in the
above reviews and more recent studies [10, 11] were prospec-
tive randomised controlled trials and only few reported a
double blind design. A recent study comparing themidvastus
approach with the medial parapatellar approach in bilateral
TKA, by Nestor et al. [10], was the only one to standardise
incision length allowing both the patient and the assessor to
be blind to group allocation.
Jarvis et al. [12] compared the knee kinematics and
kinetics during sit-to-stand transitions in patients who had
received either the standard parapatellar surgical approach
(SP) or mini-parapatellar (MP) surgical approach performed
using computer navigation. However, to the authors’ knowl-
edge no double blind randomised controlled studies have
investigated whether the recovery of gait kinematics differs
between patients undergoing surgery using either the MV
approach or the MP approach.
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Therefore, the present pilot study was designed as a
double blind randomised controlled trial to assess prospec-
tively functional outcomes in the first six months following
unilateral total knee arthroplasty using either a medial
parapatellar approach or a midvastus approach to the knee.
We hypothesised that the midvastus (MV) approach without
patellar eversion would reduce damage to the quadriceps
compared to the medial parapatellar (MP) approach and
this would result in improved recovery of function such
as gait kinematics. In addition to knee kinematics during
walking, we evaluated the outcomes in all three domains of
the International Classification of Health (ICF) [13], “Body
Structures and Function” (e.g., range of motion and muscle
strength), “Activity” (e.g., gait kinematics and Timed Up and
Go test), and Participation’ (daily step count).
2. Patients and Materials
Patients were recruited to the study from the waiting list of
two consultants with a special interest in knee arthroplasty.
Patients included were those with knee osteoarthritis and
on the waiting list for primary unilateral knee arthroplasty
and those who are fit enough to take part in the gait
analysis assessments. Exclusion criteria were a body mass
index of more than 40; a fixed valgus deformity of more
than 15 degrees; inflammatory polyarthritis; disorders of
the feet, ankles, hips, or spine causing abnormal gait or
significant pain; dementia; severe visual impairment; neu-
rological conditions affecting movement; and the inability
to give informed consent. Patients who had previously had
hip replacements or contralateral knee replacements were
not excluded, unless they had on-going pain or restricted
function.
Ethical approval was granted from the local hospital
trust and the University Research Ethics Committees. All
participants gave informed consent, signing a consent form
before participating in the study.
The study has been registered with ClinicalTrials.gov
(NCT056445).
2.1. Surgical Protocols. Knee arthroplasties were performed
using either the medial parapatellar approach or midvastus
approach. A standard 15 cm skin incision was used in all cases
so that it was not possible for the patient or the research
assessor to detect which approach had been used. PFC
Sigma cruciate retaining arthroplasty (DePuy International
Ltd, Leeds, UK) implants were used with cement and the
patella was not resurfaced. All patients had surgery under
spinal anaesthesia supplemented by a femoral nerve block.
All femoral nerve blocks were undertaken with a nerve
stimulator and 20mL of 0.25% marcaine infiltrated. They
were all effective and resulted in less than 24 hours of motor
blockade. In the postoperative period, patient controlled
analgesia was used for 24 hours. The postoperative care for
both of the patient groups was identical, using a standard care
plan which emphasizes early weight bearing and knee flexion
exercises. Discharge from hospital was dictated by individual
patient’s ability to ascend and descent a flight of stairs and
home circumstances.
Participants were randomly allocated to either the
“medial parapatellar” (MP) group or the “midvastus” (MV)
group using computer generated randomization. Cards
instructing “medial parapatellar” group or “midvastus” group
were placed in opaque sealed envelopes which were opened
when the patient was prepared and draped for surgery,
immediately before proceeding with the operation.
2.2. Outcome Measures. Patients in the study were assessed
on average 26 days before being admitted for a knee replace-
ment surgery and at six weeks, three months, and six months
after surgery. Functional assessments were performed by
a researcher who had no involvement with the patient’s
care and thus was blinded to group allocation. Tourniquet
time was recorded. The first postoperative day the patients
achieved theirmobilitymilestones (straight leg raise, progres-
sion from walking with a Zimmer frame to walking with two
sticks and independent stair climbing) was also recorded.
2.3. Laboratory Outcome Measures. The knee extensor force
was measured before surgery and at six-week, three-
month, and six-month postoperative assessments, usingMIE
myometer (MIE, Leeds, UK)with the participants sitting on a
chair with their knee in 90 degree flexion. The peak moment
calculated by multiplying the force value by the moment arm
was normalized by dividing by body weight. The maximum
value over three trials was used for analysis.
Active peak flexion and extension of the affected knee
were measured with participants being seated on a plinth.
A manual goniometer was used to measure the angle to the
nearest degree.
The Timed Up and Go test (TUG) records the time taken
to rise from a standard arm chair, walk to a line three metres
from the chair, turn around, walk back, and sit down on the
chair again [14].
Three-dimensional motion analysis using eight camera
Vicon Nexus systems was used to record the lower limb
kinematics before surgery and at the three-month and six-
month postoperative assessments. Participants had 14mm
diameter passive reflective sphere markers placed on their
lower limbs and pelvis according to the Vicon Plug-In-Gait
manual which is based on theHelenHaysmarker system [15].
Participants were asked to walk a distance of sixmetres across
the laboratory while the Vicon motion analysis system was
recording; this constituted one trial. A minimum of five trials
were recorded for each assessment.
The following parameters were retrieved for analysis:
walking speed, peak knee flexion in swing, peak knee exten-
sion in stance, knee range of motion during the stance phase
(load acceptance), and knee and hip range of motion over the
entire gait cycle.
2.4. Patient Reported Outcomes and Activity Monitoring.
Patients were asked to complete the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC).
Daily physical activity was estimated using an activPAL
activity monitor [16]. Participants were given the activity
monitor at the presurgery and the six-month assessments and
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Figure 1: Consort flow diagram of the study.
were asked to wear the monitor for a minimum of five days,
including at least one day over the weekend.
2.5. Statistical Analysis. An independent 𝑡-test or the Mann-
Whitney 𝑈 test for nonparametric data was used to com-
pare differences between the two groups before surgery.
Differences between the two groups were analysed using
repeated measures two-way analysis of variance (ANOVA).
To account for possible differences between the groups at
baseline preoperative measures were used as covariant. Level
of statistically significant difference was set at 𝑃 < 0.05.
Cohen’s effect size 𝑑 was calculated to inform sample size
for future, appropriately powered, larger scale trials. Effect
sizes were defined to be medium for values for Cohen’s 𝑑 of
more than 0.3 but less than 0.5, good for values of 0.5 and
greater but less than 0.8, and large for values of 0.8 and greater
[17]. Statistical calculations were performed using Statistical
Package for Social Sciences (SPSS), version 19.
3. Results
Two hundred and eight patients with osteoarthritis were
identified and after application of the exclusion criteria 120
were invited to take part in the study, 31 of whom attended for
the preoperative assessment. Of those 31 patients, the surgery
of three patients was cancelled, resulting in a total of 28
patients randomized to either approach. Sixteen had amedial
parapatellar approach and 12 had a midvastus approach. The
CONSORT flow diagram is included in Figure 1.
3.1. Effects of Surgical Approach. A comparison of the two
groups for participants’ demographic and baseline char-
acteristics is shown in Table 1. There were no statistically
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Table 1: Mean (std) values of the preoperative measures for the medial parapatellar (MP) and midvastus (MV) groups.
Intention to treat Per protocol
MP (𝑛 = 16) MV (𝑛 = 12) 𝑃 value MP (𝑛 = 12) MV (𝑛 = 11) 𝑃 value
Age (yrs) 70 (8) 73 (8) 0.227 71 (7) 74 (8) 0.371
Gender (male : female) 8/8 8/4 0.209¥ 7/5 7/4 0.681¥
BMI (kg/m2) 29.3 (3.4) 31.1 (4.4) 0.240 28.9 (2.6) 31.2 (4.3) 0.056
TUG (s) 11.5 (4.1) 11.3 (2.9) 0.874 10.5 (2.3) 11.5 (2.9) 0.406
Active flexion (∘) 111 (13) 106 (19) 0.434 109 (13) 105 (18) 0.519
Extensor strength (Nm/kg) 0.50 (0.21) 0.48 (0.18) 0.808 0.52 (0.22) 0.45 (0.18) 0.533
WOMAC pain (max 20)∗ 9.4 (3.3) 8.7 (3.1) 0.537 9.4 (3.2) 8.6 (3.1) 0.427
WOMAC stiffness (max 8)∗ 4.8 (1.2) 3.8 (1.5) 0.048 4.8 (1.8) 3.9 (1.5) 0.054
WOMAC function (max 96)∗ 31.2 (9.4) 28.0 (10.3) 0.402 30.3 (10.1) 27.1 (11.0) 0.495
∗A higher value means more pain, more stiffness, and a decreased function.
¥Fisher’s exact test.
Table 2: Mean (std) values of the in-patient postoperative measures for the medial parapatellar (MP) and midvastus (MV) groups. 𝑃 value
of independent 𝑡-tests unless stated otherwise.
MP MV 𝑃 value Difference and 95% CI
Tourniquet time (min) 61 (15) 49 (8) 0.029 11 (1 : 22)
Active flexion day 1 (∘) 39 (14) 43 (17) 0.582 4 (−9 : 16)
Active flexion day 2 (∘) 56 (17) 61 (18) 0.470 −5 (−9 : 18)
Active flexion day 3 (∘) 70 (19) 75 (16) 0.491 −5 (−10 : 20)
Days until straight leg raise 3.9 (2.7) 2.6 (1.4) 0.338¥ −1.3 (−3.4 : 0.9)
Days until two walking sticks 4.0 (2.3) 3.2 (0.6) 0.605¥ −0.8 (−2.3 : 0.7)
Days until stair negotiation 5.0 (2.7) 4.1 (1.3) 0.461¥ −0.9 (−2.8 : 1.0)
Length of hospital stay 5.3 (2.8) 5.2 (2.9) 0.978¥ −0.1 (−2.5 : 2.2)
¥Nonparametric Mann-Whitney 𝑈 test.
significant differences between the MP and MV groups with
regard to age, gender, and preoperative range of motion.
3.1.1. Hospital Outcomes Recordedwithin aWeek from Surgery.
Outcomes recorded during hospital stay are shown in Table 2.
Tourniquet time was significantly shorter in the MV group
(49 versus 61minutes,𝑃 = 0.029), but when surgeonwas used
as covariate, this difference was not statistically significant
(𝑃 = 0.1).
The MV group showed up to 5 degrees more ROM in the
first, second, and third days after surgery and achieved their
mobility milestones earlier. Straight leg raise was achieved 1.3
days earlier (95%Confidence Interval:−3.4 to 0.7, Cohen’s𝑑 =
0.63), progression from a walker to two walking sticks was
achieved 0.8 days earlier (CI: −2.3 to 0.7, Cohen’s 𝑑 = 0.55),
and stair negotiation was achieved 0.9 days earlier (CI −2.8 to
1.0, Cohen’s 𝑑 = 0.50) in the MV group compared to the MP
group. However, although possibly clinically relevant with
good effect sizes (Cohen’s 𝑑 ≥ 0.5), none of these advantages
of the MV approach over the MP approach were statistically
significant in this pilot study. Interestingly, although the
clinical pathway states that patients are ready to be discharged
once they can safely negotiate a flight of stairs, unlike days
to stair negotiation, days to discharge did not show a trend
towards an advantage of the MV approach (5.3 days versus
5.2 days; Cohen’s 𝑑 = 0.04).
3.1.2. Laboratory and Self-Reported Outcomes. Table 3 shows
the results of the measurements of knee extensor strength,
active knee flexion, TUG, and the WOMAC. Knee extensor
strength was lower relative at the six week post surgery
assessment, knee extensor strength had decreased compared
to before surgery in the MP group, while in the MV group
knee extensor strength was slightly improved (changes: MP
−0.09Nm/kg versus MV 0.06Nm/kg, Cohen’s 𝑑 = 0.73,
𝑃 = 0.269). Figure 2 shows the recovery profiles of extensor
strength. No differences between the groups in the rate of
improvement of active knee flexion or TUG were observed.
Knee and hip kinematics and daily step count are shown
in Table 4. None of these outcomes showed statistically or
clinically significant differences between two groups.
4. Discussion
The purpose of this study was to detect differences in
the recovery of knee function following knee replacement
surgery using two different approaches, the medial para-
patellar and the midvastus without patellar eversion. The
assessments focused on functional outcomemeasures during
the recovery from knee replacement in the first six months.
We did not attempt to compare pain medication levels in the
two groups which has been the subject of previous studies
[18, 19] investigating the effects of surgical approach.
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Table 3: Mean (std) values of the pre- and postoperative function measures for the MP and MV groups. 𝑃 value for the effect of the type of
surgery.
Before surgery 6 weeks 3 months 6 months 𝑃 value
Knee extensor strength (Nm/kg) MP 0.52 (0.22) 0.43 (0.13) 0.48 (0.09) 0.61 (0.25) 0.269
MV 0.45 (0.18) 0.51 (0.25) 0.52 (0.23) 0.64 (0.25)
Active flexion (∘) MP 109 (13) 95 (15) 103 (6) 104 (7) 0.283
MV 105 (18) 90 (13) 98 (12) 100 (14)
TUG (s) MP 10.5 (2.3) 11.0 (2.7) 9.5 (2.1) 9.5 (2.8) 0.387
MV 11.5 (2.9) 11.5 (2.5) 11.4 (3.0) 10.5 (2.1)
WOMAC pain (max 20) MP 9.4 (3.2) 5.5 (2.5) 4.3 (2.8) 3.8 (3.1)
∗
0.907
MV 8.6 (3.1) 5.1 (3.6) 4.7 (4.3) 3.2 (3.6)
WOMAC stiffness (max 8) MP 4.8 (1.8) 2.8 (1.8) 2.7 (1.7) 2.5 (1.4) 0.799
MV 3.9 (1.5) 2.7 (1.5) 1.9 (1.2) 2.6 (1.3)
WOMAC function (max 96) MP 30.3 (10.1) 16.7 (10.8) 14.4 (9.8) 14.6 (11.1) 0.964
MV 27.1 (11.0) 14.8 (10.5) 13.9 (13.0) 13.8 (10.6)
∗Nonparametric Mann-Whitney 𝑈 test.
The results of this study suggest that the MV group
showed earlier achievement of mobility milestones such as
straight leg raise, progression from a walker to two walking
sticks, and independent stair negotiation. The difference
between surgical approaches with regard to “days to straight
leg raise” found in our study (1.3 days) is similar to previous
studies reporting statistically significant differences of 1.1
days [20] and 1.5 days [21] in favour of the MV approach.
White et al [22] also reported that patients who underwent
a MV approach were more likely to be able to achieve a
straight leg raise at 8 days post-surgery compared to MP
approach. In addition, the current study showed a trend
towards quicker recovery of the muscle function in the
MV group. On average, participants in the MV group had
increased their knee extensor strength at six weeks and three
months relative to before surgery, while those in the MP
group showed a decrease in strength at those time points.
Nestor et al [10] reported improved reported strength three
weeks after surgery in participants who underwent the MV
approach compared to the MP approach, but this benefit did
not last at six and twelve weeks after surgery.
Early knee flexion showed small advantages in the MV
group participants over the MP group participants. Mean
peak flexion over the first three days was 5 degrees higher in
the MV group. In comparison, the meta-analysis by Alcelik
et al. [4] showed significantly higher differences in flexion at
one week. (8.88 degrees, 95% confidence interval (CI) 4.50
to 13.25, 𝑃 < 0.01) in favour of the MV approach, while
Karachalios et al. [9] reported differences in favour of the
midvastus approach ranging from 51 days at day 1 to 32
degrees at day 21. The meta-analysis by Liu and Yang [3] also
showed higher knee ROM at day 1 and at three months after
surgery.
Functional outcomes measured by the WOMAC score,
knee ROMassessed by gait analysis and daily physical activity
at three and six months measured by activPAL, did not
show any benefits of the MV approach. The lack of an effect
of comparing the MV and MP approaches on functional
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Figure 2: Graphical representation of the recovery of the knee
extensor strength in the midvastus (MV) group and the medial
parapatellar (MP) group.
outcomes such as the KSS was also reported in a meta-
analysis by Alcelik et al. [4] who did however conclude that
pain in the first week after surgery was reduced in the MV
group relative to the MP group. Pain scores in the first week,
however, are difficult to compare amongst different studies as
this highly depends on the pain medication protocols in the
first days after surgery.
This study has several limitations. Firstly, the current
study was a pilot study and the limited number of partic-
ipants negatively impacted the power to detect statistically
significant differences between the groups. Secondly, the
participants in the trial were only a small proportion of those
undergoing surgery at our hospital during the study period
(31/208, 14.9%), which limits the generalizability of the results
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Table 4: Mean (std) values of the pre- and postoperative gait characteristics of the medial parapatellar (MP) and midvastus (MV) groups. 𝑃
value for the effect of surgical approach.
Before surgery 3 months 6 months 𝑃 value
Walking speed (m/s) MP 0.83 (0.18) 0.90 (0.22) 0.96 (0.15) 0.666
MV 0.80 (0.15) 0.84 (0.21) 0.88 (0.18)
Knee ROM Gait Cycle (∘) MP 42.8 (10.3) 41.9 (11.4) 45.8 (9.7) 0.811
MV 43.7 (7.9) 40.4 (10.5) 43.4 (9.6)
Knee ROM in stance (∘) MP 5.1 (3.0) 5.4 (2.9) 5.8 (2.8) 0.983
MV 6.3 (4.0) 6.5 (3.3) 7.1 (3.2)
Peak extension stance (∘) MP 8.8 (9.2) 8.4 (5.8) 6.3 (7.6) 0.599
MV 7.0 (6.4) 8.6 (5.2) 3.7 (6.5)
Hip ROM gait cycle MP 36.9 (8.4) 39.1 (8.1) 40.0 (7.1) 0.670
MV 35.7 (4.3) 36.3 (8.2) 38.3 (6.5)
Steps per day MP 5613 (2505) NM 5786 (1916) 0.126
MV 6342 (2695) NM 6822 (2363)
of the study. Also, two surgeons performed the surgery in
this trial which may introduce heterogeneity of the data.
Finally, knee kinematics during walking were not recorded
at 6 weeks after surgery as it was thought that this may be too
demanding for participants.However, thismayhave provided
more insights into objective function in the early stages of the
recovery.
To the authors’ knowledge, this current randomized
controlled trial is the first study investigating the difference in
knee kinematics of unilateral TK between the MV approach
and MP approach which allowed double blinding because
of similar incision length in both approaches. In addition,
the effect of surgical approach in this pilot study was
assessed on a whole range of outcome measures in all three
domains of the ICF. Objective outcomes of function such
gait analysis were assessed in addition to outcomes such as
achievement of mobility milestones and days until discharge
which are important from the health economics point of
view.
Although surgical approach did not appear to affect
function past 6 weeks post surgery, good effect sizes found
for outcomes in the first 6 weeks indicated a benefit of the
MV approach regarding the achievement of early mobility
milestones and in the early recovery of muscle strength
without compromising on surgical duration. As these trends
confirmed by results from previous studies are of interest for
both patients’ benefit and the health economic point of view,
a future appropriately powered trial with a similar design but
including a health economic analysis is warranted. Based on
the effect sizes in this pilot study, a power calculation for
such a future trial suggest that 85 participants in each group
would be required to detect an effect size of 0.5 (days until
patient meet physiotherapy discharge criteria) or 41 in each
group to detect an effect size of 0.73 (knee extensor strength
at 6 weeks). In addition, further investigations should be
carried out into how the apparently early advantage of theMV
approach can be maintained for a longer term.
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